JNJ

Johnson & Johnson · DUS:JNJ

239.85 EUR−6.70 −2.72%

Johnson & Johnson (DUS:JNJ) last traded at 239.85 EUR, down 2.72% on the day. Over the past year the stock is up 47.17%. Its 52-week range is 160.50 to 250.25. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open243.10

Day range239.15 – 243.65

52-week range160.50 – 250.25

Volume4

Average volume (10 days)6

Market cap (USD)657.68 B

P/E41.22

EPS (TTM) (USD)6.59

Dividend yield1.93%

Beta (1 year)−0.0487

Revenue (TTM) (USD)99.35 B

Employees140.80 K

Performance

+1.89%1 week

+4.35%1 month

+8.36%3 months

+24.78%6 months

+36.48%Year to date

+47.17%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Johnson & Johnson reports 94% success rate in trial of coronary artery deviceSeeking Alpha · 01 Nov 2026
Johnson & Johnson reports lower mortality rates with Impella heart pumpsSeeking Alpha · 01 Nov 2026
J&J Reports Positive Survival And Outcomes With Impella In HrpciReuters · 01 Nov 2026
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study ResultsBusinessWire · 01 Nov 2026
Ayushman Bharat Digital Mission Can Transform Healthcare Through Data, Says NITI Aayog MemberBusinessworld · 01 Nov 2026
JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Zacks · 30 Oct 2026
Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmarkMint · 29 Oct 2026
Over 100 of the 600-plus medicines listed by NPPA do not show a drop in pricesBusiness Line · 29 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.